General Information of Drug (ID: DMA6P4J)

Drug Name
2-(Carbazole-9-sulfonyl)-benzoic acid Drug Info
Synonyms CHEMBL364141; 2-(Carbazole-9-sulfonyl)-benzoic acid
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
44393734
TTD Drug ID
DMA6P4J

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID27109571-Compound-27 DMXRTH4 N. A. N. A. Patented [2]
PMID27109571-Compound-31 DMU690T N. A. N. A. Patented [2]
PMID27109571-Compound-16 DMZI25U N. A. N. A. Patented [2]
PMID27109571-Compound-14 DMVY6B9 N. A. N. A. Patented [2]
PMID27109571-Compound-25 DM435GR N. A. N. A. Patented [2]
PMID27109571-Compound-30 DM24FSP N. A. N. A. Patented [2]
PMID27109571-Compound-29 DMDMEHQ N. A. N. A. Patented [2]
PMID27109571-Compound-18 DM4S5ME N. A. N. A. Patented [2]
PMID27109571-Compound-28 DMTZVY3 N. A. N. A. Patented [2]
PMID27109571-Compound-20 DMQU9XP N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID27109571-Compound-27 DMXRTH4 N. A. N. A. Patented [2]
PMID27109571-Compound-31 DMU690T N. A. N. A. Patented [2]
PMID27109571-Compound-16 DMZI25U N. A. N. A. Patented [2]
PMID27109571-Compound-14 DMVY6B9 N. A. N. A. Patented [2]
PMID27109571-Compound-25 DM435GR N. A. N. A. Patented [2]
PMID27109571-Compound-30 DM24FSP N. A. N. A. Patented [2]
PMID27109571-Compound-29 DMDMEHQ N. A. N. A. Patented [2]
PMID27109571-Compound-18 DM4S5ME N. A. N. A. Patented [2]
PMID27109571-Compound-28 DMTZVY3 N. A. N. A. Patented [2]
PMID27109571-Compound-20 DMQU9XP N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fatty acid-binding protein 4 (FABP4) TTHWMFZ FABP4_HUMAN Inhibitor [1]
Fatty acid-binding protein 5 (FABP5) TTNT2S6 FABP5_HUMAN Inhibitor [1]

References

1 Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.
2 Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76.